Cape Fear BioCapital

Directory portfolio

• Incyclix Bio

  Selective CDK2 inhibitor developer advancing INX-315 for CDK4/6-resistant ER+/HER2- breast cancer and CCNE1-amplified solid tumors.

• iOrganBio

  AI-powered cell manufacturing platform for human cell production

• Thoracic Innovations

  Medical device company developing surgical tools for cardiothoracic disease